About the Award
The annual Distinguished Alumnus Award & Lecture is sponsored by the MD Anderson Alumni Association and was established in 1980 to recognize a prominent alumnus who has made distinguished contributions to his or her respective field. The recipient of this award is selected from nominations received by the Alumni Association. Candidates must have trained at The University of Texas MD Anderson Cancer Center.
2022 Distinguished Alumnus Call for Nominations
The MD Anderson Office of Alumni Relations is pleased to announce a Call for Nominations for the 2022 MD Anderson Distinguished Alumnus Award. Nominations will be accepted through November 30, 2021. For a complete list of criteria and to submit your nomination, please use the link below.
Meletios A. Dimopoulos, M.D.
MD Anderson Distinguished Alumnus for 2021
Meletios A. Dimopoulos, MD, is Professor and Chairman of the Department of Clinical Therapeutics at the National and Kapodistrian University of Athens School of Medicine in Athens, Greece. He was elected Vice Dean of the Medical School for the academic years 2007-2011 and Dean for the academic years 2011-2015. In February 2015, he was elected Rector of the National and Kapodistrian University of Athens for a 4-year term. He obtained his medical degree from the National and Kapodistrian University of Athens in 1985; completed a residency in internal medicine at the Royal Victoria Hospital, McGill University, Montreal, Canada; and completed a fellowship in hematology/oncology at The University of Texas MD Anderson Cancer Center.
Dr. Dimopoulos has authored more than 1113 publications in peer-reviewed journals, as well as numerous abstracts and several textbook chapters primarily focusing on plasma cell dyscrasias and genitourinary and gynecologic cancers. He has more than 72,000 citations and an h-index of 119 in Scopus and more than 59,000 citations and an h-index of 110 in Web of Science. He is a reviewer for several journals, including The New England Journal of Medicine, Blood, Journal of Clinical Oncology, Haematologica, Leukemia, Cancer, European Journal of Haematology, and Leukemia and Lymphoma. Dr. Dimopoulos was Associate Editor of the European Journal of Internal Medicine (2001-2007) and is an Associate Editor of Current Hematologic Malignancy Reports. He also has been an Editorial Board Member for Journal of Clinical Oncology, Haematologica, Leukemia and Lymphoma, Clinical Lymphoma, Myeloma and Leukemia, Expert Review of Hematology, and Blood Advances.
Dr. Dimopoulos serves on the Scientific Advisory Boards of the International Myeloma Foundation and International Waldenstrom’s Macroglobulinemia Foundation, and he is a Member of the Board of the European Myeloma Network. Dr. Dimopoulos organized the XIth International Myeloma Workshop and IVth International Workshop on Waldenstrom’s Macroglobulinemia (Kos Island, Greece; June 2007). In March 2013, Dr. Dimopoulos was elected a Member of the Board of the International Myeloma Society, where he served through 2017.
Currently, Dr. Dimopoulos is the Chairman of the Greek Myeloma Study Group and of the Balkan Myeloma Study Group. He also serves as Chairman of the Board of the Foundation of the Julia and Alexander N. Diomedes Botanic Garden and is a member of the Board of the National Greek Committee for UNESCO.